What are the reported procedural costs of vascular access surgery?
The Journal of Vascular Access · 2025-09 · 26 (5) · 1510-1519
DOI: 10.1177/11297298241284737 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Vascular Access, online erschienen am 30.09.2024. Verfasst von Ben Edgar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Renal Transplant and Vascular Access Surgery, Queen Elizabeth University Hospital, Glasgow, UK. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Health Care Costs, Renal Dialysis, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Kidney Research UK.
Abstract (Originalsprache)
Introduction
Since the inception of arteriovenous grafts (AVG) as a novel technique, there has been greater emphasis on the assessment of outcomes rather than costs. Gross-costing methods over-simplify vascular access surgery and do not reflect the true costs of the service, preventing accurate cost-effectiveness analysis. The aim of this study is to assess the reporting of procedural costs of arteriovenous access creation in economic analyses of vascular access surgery, and to compare the reported costs of the two most performed procedures – arteriovenous fistula (AVF) and arteriovenous graft (AVG).
Methods
This systematic review included studies reporting a per-procedure cost for AVF or AVG creation. Costs were adjusted from original to target price year using a Gross Domestic Product (GDP) deflator index and converted to 2021 US Dollars using conversion rates based on purchasing power parities.
Results
The results demonstrate wide discrepancy in the reported procedural costs of arteriovenous access creation. Most of the data represents retrospectively observed costs rather than prospective data collected on an intention-to-treat basis. Charges are frequently presented in lieu of costs, and aggregated gross-costing methodology predominates rather than more accurate micro-costing.
Conclusion
Future micro-costing studies of vascular access surgery are essential to allow a greater understanding of cost-drivers and allow accurate cost-effectiveness analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renal Transplant and Vascular Access Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
- School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
- Independent Health Economist, Healthonomics UK Ltd, Reading, UK.
- Department of Renal Medicine, Queen Elizabeth University Hospital, Glasgow, UK.
- Department of Interventional Radiology, Queen Elizabeth University Hospital, Glasgow, UK.
ORCID-Profile: Ben Edgar, Peter Thomson, Callum Stove, David B Kingsmore
Förderung
- Kidney Research UK
Zitieren
APA
Edgar, B., Jones, C., Aitken, E., Stevenson, K., Jackson, A., Gaianu, L., Thomson, P., Kasthuri, R., Stove, C., & Kingsmore, D. B. (2025). What are the reported procedural costs of vascular access surgery?. The Journal of Vascular Access, 26(5), 1510-1519. https://doi.org/10.1177/11297298241284737
Vancouver
Edgar B, Jones C, Aitken E, Stevenson K, Jackson A, Gaianu L, et al. What are the reported procedural costs of vascular access surgery?. The Journal of Vascular Access. 2025;26(5):1510-1519. doi:10.1177/11297298241284737
BibTeX
@article{Edgar2025,
author = {Edgar, Ben and Jones, Catrin and Aitken, Emma and Stevenson, Karen and Jackson, Andrew and Gaianu, Lucian and Thomson, Peter and Kasthuri, Ram and Stove, Callum and Kingsmore, David B},
title = {What are the reported procedural costs of vascular access surgery?},
journal = {The Journal of Vascular Access},
year = {2025},
volume = {26},
number = {5},
pages = {1510--1519},
doi = {10.1177/11297298241284737}
}
EUVIMED